Why It Matters
The company filed its second-quarter lobbying disclosure for $330,000, continuing a pattern from recent quarters. The general areas of interest include consumer issues/safety, pharmacy, and taxation.
By the Numbers
Walgreens filed $330,000 in lobbying expenditures July 27. Madeline Hodge served as the sole in-house lobbyist listed, representing a change from earlier quarters when Isaac Fordjour also appeared on the roster. Hodge has been a consistent in-house presence throughout the past year.
On the external front, Walgreens engaged Ballard Partners LLC, Forbes Tate Partners LLC, BGR Government Affairs LLC, GuidePostStrategies LLC, and S-3 Group LLC.
Spending remained flat compared to the first quarter of 2026, when the company also reported $330,000 though in-house expenditures. That represented a decrease from the fourth quarter of 2025, which totaled $450,000.
Broader Context
Walgreens' recent lobbying history reveals focus on several legislative priorities. The company has consistently lobbied on the Combating Organized Retail Crime Act, which would establish a federal coordination center to address organized theft rings. Walgreens, Target, and Kroger have urged swift passage, citing increased violence, losses, and urgent holiday-season threats.
The 2026 Consolidated Appropriations Act included sweeping pharmacy benefit manager reforms and earmarked $321 million in federal funding to lower drug costs and increase price transparency.
The Bottom Line
Walgreens continues legislative advocacy at a consistent spending level. The company maintains both in-house and external lobbying capacity as it navigates ongoing changes to pharmacy regulation and retail operations.
***
Access the Legis1 platform for comprehensive political news, data, and insights.
---
Spot something wrong? Report an issue with this article